Evidence map›Paper›PMID 28255358›Full record

ArticleTheranostics2017

miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.

Jing Shi, Yihua Bei, Xiangqing Kong, Xiaojun Liu, Zhiyong Lei, Tianzhao Xu, Hui Wang, Qinkao Xuan, Ping Chen, Jiahong Xu and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Theranostics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 132 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 2 syntheses or guidelines pooled it, 215 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Exercise-induced cardiac hypertrophy: cellular and molecular mechanisms of cardiac adaptation following physical activity.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026
    Review
  7. LncRNA KCNQ1OT1 aggravates myocardial ischemia/reperfusion injury by mediating the EZH2/TIMP-3 axis.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Exercise Prescription in Cardio-Oncology.Journal of clinical medicine · 2025
    Review
  19. Review
  20. Exosomes and microRNAs as mediators of the exercise.European journal of medical research · 2025
    Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Jing ShiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yihua BeiCardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.
Xiangqing KongDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xiaojun LiuMassachusetts General Hospital Cardiovascular Division and Harvard Medical School, Boston, MA 02115, USA.
Zhiyong LeiLaboratory of Experimental Cardiology, University Medical Centre Utrecht, Utrecht 3508GA, The Netherlands.
Tianzhao XuCardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.
Hui WangDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Qinkao XuanDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Ping ChenCardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.
Jiahong XuDepartment of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Lin CheDepartment of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Hui LiuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jiuchang ZhongState Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Joost Pg SluijterLaboratory of Experimental Cardiology, University Medical Centre Utrecht, Utrecht 3508GA, The Netherlands.
Xinli LiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Anthony RosenzweigMassachusetts General Hospital Cardiovascular Division and Harvard Medical School, Boston, MA 02115, USA.
Junjie XiaoCardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China.
Shanghai University · CNJiangsu Province Hospital · CNNanjing Medical University · CNTongji Hospital · CNHarvard University · USMassachusetts General Hospital · US

Funding

The role of C/EBPbeta and CITED4 in the heartR01HL110733 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2011 to 2015
$2.1M
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MIUH2TR000901 · NCATS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DAS, SAUMYA, KWONG, RAYMOND Y · 2013 to 2014
$1.1M
Micro-RNA regulation of the cardiac exercise responseR21HL114352 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSENZWEIG, ANTHONY · 2013 to 2014
$474k
NCATS NIH HHS UH2 TR000901NHLBI NIH HHS R01 HL110733NHLBI NIH HHS R21 HL114352
6 · The paper itself

Abstract

Limited microRNAs (miRNAs, miRs) have been reported to be necessary for exercise-induced cardiac growth and essential for protection against pathological cardiac remodeling. Here we determined members of the miR-17-92 cluster and their passenger miRNAs expressions in two distinct murine exercise models and found that miR-17-3p was increased in both. miR-17-3p promoted cardiomyocyte hypertrophy, proliferation, and survival. TIMP-3 was identified as a direct target gene of miR-17-3p whereas PTEN was indirectly inhibited by miR-17-3p. Inhibition of miR-17-3p

Indexed as

Physical Conditioning, AnimalAnimalsCell ProliferationCell SurvivalHeartHypertrophyMiceMicroRNAsMyocardial IschemiaMyocytes, CardiacRatsReperfusion InjuryMicroRNAsMirn17 microRNA, mouseCardiac growthExercisemicroRNA.

Identifiers

PMID28255358
PMCPMC5327641
OpenAlexW2590587477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.